OM

Opaleye Management Portfolio holdings

AUM $494M
1-Year Est. Return 68.17%
This Quarter Est. Return
1 Year Est. Return
+68.17%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$449M
AUM Growth
-$122M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
54
New
Increased
Reduced
Closed

Top Buys

1 +$34.4M
2 +$10.2M
3 +$8.29M
4
ANIK icon
Anika Therapeutics
ANIK
+$5.94M
5
PVLA
Palvella Therapeutics
PVLA
+$4.82M

Top Sells

1 +$68M
2 +$20.1M
3 +$9.58M
4
JSPR icon
Jasper Therapeutics
JSPR
+$8.55M
5
NAMS icon
NewAmsterdam Pharma
NAMS
+$8.35M

Sector Composition

1 Healthcare 97.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HROW icon
1
Harrow
HROW
$1.4B
$105M 23.42%
3,955,000
-35,000
ETON icon
2
Eton Pharmaceutcials
ETON
$492M
$37M 8.24%
2,852,070
SNWV
3
SANUWAVE Health Inc
SNWV
$300M
$34.4M 7.65%
+972,002
LQDA icon
4
Liquidia Corp
LQDA
$2B
$33.3M 7.42%
2,260,000
+561,858
RYTM icon
5
Rhythm Pharmaceuticals
RYTM
$7.38B
$26M 5.78%
490,000
-10,000
CDXS icon
6
Codexis
CDXS
$238M
$25.6M 5.69%
9,500,000
+660,000
IMNM icon
7
Immunome
IMNM
$1.44B
$23.9M 5.32%
3,550,000
+1,510,000
TGTX icon
8
TG Therapeutics
TGTX
$5.53B
$21.1M 4.7%
535,000
-1,725,000
ARVN icon
9
Arvinas
ARVN
$711M
$13.9M 3.09%
1,975,000
+350,000
OCUL icon
10
Ocular Therapeutix
OCUL
$2.59B
$11.7M 2.6%
1,595,000
-2,747,500
EWTX icon
11
Edgewise Therapeutics
EWTX
$1.61B
$8.69M 1.93%
395,000
-85,000
TARA icon
12
Protara Therapeutics
TARA
$223M
$7.37M 1.64%
1,730,000
-95,000
DNA icon
13
Ginkgo Bioworks
DNA
$895M
$6.81M 1.52%
1,195,000
-5,000
ANIK icon
14
Anika Therapeutics
ANIK
$131M
$5.94M 1.32%
+395,000
PTGX icon
15
Protagonist Therapeutics
PTGX
$4.71B
$5.08M 1.13%
105,000
XOMA icon
16
Xoma
XOMA
$441M
$5.04M 1.12%
253,043
+3,043
TRVI icon
17
Trevi Therapeutics
TRVI
$1.29B
$5M 1.11%
795,000
-1,522,500
PVLA
18
Palvella Therapeutics
PVLA
$809M
$4.82M 1.07%
+172,357
GOSS icon
19
Gossamer Bio
GOSS
$529M
$4.72M 1.05%
4,287,415
-202,585
ANAB icon
20
AnaptysBio
ANAB
$962M
$4.66M 1.04%
+250,933
IRON icon
21
Disc Medicine
IRON
$2.59B
$4.22M 0.94%
+85,000
LRMR icon
22
Larimar Therapeutics
LRMR
$365M
$4.12M 0.92%
+1,914,077
CGON icon
23
CG Oncology
CGON
$3.19B
$4.02M 0.89%
+163,988
SLRN
24
DELISTED
ACELYRIN
SLRN
$3.99M 0.89%
1,615,000
-620,000
RCEL icon
25
Avita Medical
RCEL
$145M
$3.58M 0.8%
+440,000